CRIS Current Research Information System

AMBROSIONI, ETTORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.059
AS - Asia 3.873
EU - Europa 3.686
SA - Sud America 231
AF - Africa 179
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.018
GB - Regno Unito 1.387
SG - Singapore 1.120
CN - Cina 1.036
VN - Vietnam 870
IT - Italia 571
DE - Germania 424
UA - Ucraina 273
FR - Francia 260
IN - India 241
HK - Hong Kong 238
SE - Svezia 212
RU - Federazione Russa 208
BR - Brasile 176
IE - Irlanda 105
ZA - Sudafrica 94
JP - Giappone 84
EE - Estonia 81
KR - Corea 74
PH - Filippine 33
FI - Finlandia 32
NL - Olanda 28
AR - Argentina 27
BD - Bangladesh 26
SC - Seychelles 26
ID - Indonesia 25
TG - Togo 22
CA - Canada 20
IQ - Iraq 20
PL - Polonia 20
CI - Costa d'Avorio 17
JO - Giordania 15
MX - Messico 15
TH - Thailandia 15
TR - Turchia 15
CH - Svizzera 14
BE - Belgio 13
GR - Grecia 11
BG - Bulgaria 10
EC - Ecuador 9
LB - Libano 9
PK - Pakistan 9
TW - Taiwan 9
UZ - Uzbekistan 8
AT - Austria 7
RO - Romania 6
HU - Ungheria 5
SA - Arabia Saudita 5
CL - Cile 4
MY - Malesia 4
PE - Perù 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
ES - Italia 3
MA - Marocco 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
CV - Capo Verde 2
EG - Egitto 2
GH - Ghana 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
LV - Lettonia 2
ME - Montenegro 2
PA - Panama 2
PY - Paraguay 2
AO - Angola 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
IR - Iran 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.033
Salva come PNG Salva come JPEG
Città #
Southend 1.293
Singapore 734
Santa Clara 381
Fairfield 296
Ashburn 294
San Jose 274
Hong Kong 225
Wilmington 213
Chandler 197
Princeton 193
Hefei 176
Jacksonville 169
Ho Chi Minh City 168
Dong Ket 144
Woodbridge 136
Hanoi 135
Seattle 134
Houston 112
Cambridge 111
Beijing 110
Boardman 108
Dublin 105
Lauterbourg 103
Ann Arbor 98
Westminster 95
Padova 91
Nanjing 89
Turin 84
Berlin 79
Tokyo 79
Seoul 69
Los Angeles 59
Milan 53
Buffalo 51
Medford 51
Dallas 47
New York 44
Saint Petersburg 41
Shenyang 40
Jinan 37
Helsinki 30
Nanchang 29
Hebei 24
Jiaxing 24
Mahé 24
Changsha 23
Da Nang 23
Guangzhou 23
Mülheim 23
San Diego 23
Lomé 22
Norwalk 22
Phoenix 22
Dearborn 21
Haiphong 21
Tianjin 21
Verona 21
Zhengzhou 19
Abidjan 17
Bologna 17
Olalla 17
Redondo Beach 17
Shanghai 17
Rome 16
Warsaw 16
Amman 15
São Paulo 15
Bengaluru 14
Frankfurt am Main 14
Bremen 13
Orem 13
Ningbo 12
Council Bluffs 11
Munich 11
Shenzhen 11
Atlanta 10
Brussels 10
Hải Dương 10
Manila 10
Baghdad 9
Biên Hòa 9
Brooklyn 9
Sofia 9
Zelarino 9
Amsterdam 8
Bangkok 8
Bern 8
Chennai 8
Haikou 8
Kunming 8
Montreal 8
Phủ Lý 8
Quận Bình Thạnh 8
Taiyuan 8
The Dalles 8
Xi'an 8
Chicago 7
Dhaka 7
Falls Church 7
Jakarta 7
Totale 7.788
Salva come PNG Salva come JPEG
Nome #
Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program. 508
Tolerability of nebivolol in head-to head clinical trials vs. other cardioselective beta-blockers in the treatment of hypertension. A meta-analysis. 282
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4. 214
Confronto tra BNP e NT-proBNP nella valutazione dei pazienti con insufficienza cardiaca di origine ipertensiva e non ipertensiva 197
Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study 196
BNP e parametri ecocardiografici in pazienti con insufficienza cardiaca. 183
Assessment of b-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP in hypertensive patients with heart failure 181
BNP e NT-proBNP nella valutazione dei pazienti con insufficienza cardiaca di origine ipertensiva e non ipertensiva. 155
Confronto tra BNP e NT-proBNP nel monitoraggio dei pazienti ipertesi con insufficienza cardiaca 154
Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: A pooled individual data analysis of four randomized, double-blind, controlled, prospective studies 149
Cardiomiopatia peripartum: stato di avanzamento della proposta di un registro italiano. 148
Manometric brachial arteriography, a new technique for non invasive high-precision blood pressure measurement:development and validation through comparison with intra-arterial blood pressure 147
Revisione critica del ruolo della digitale nel trattamento del paziente con scompenso cardiaco. 143
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Heart Study. 143
Approccio integrato alle linee guida sul trattamento del paziente a rischio cardiovascolare 140
Zofenopril 15 anni con il cuore nel cuore. 138
Il significato clinico degli acufeni nei pazienti con scompenso cardiaco. 132
Valutazione di peptide natriuretico atriale di tipo B (BNP) e di frammento N-terminale di pro-BNP in pazienti con insufficienza cardiaca di varia eziologia. 132
Il significato clinico degli acufeni nei pazienti con scompenso cardiaco 131
An integrated approch to care on heart failure patients with hypertension: effects on NYHA class and hospitalization. 130
Efffects of telmisartan and bisoprolol on blood pressure, peripheral haemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients. 128
Effects of early Ace-inhibition in patients with acute myocardial infarction and metabolic syndrome. 127
New pharmacological treatments of acutely decompensated heart failure. Critical review of new drugs options. 126
Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients 126
Il ruolo dei FANS nell'instabilizzazione del quadro clinico dei pazienti con insufficienza cardiaca. 125
La percezione clinica del rischio cardiovascolare. Il questionario. 124
Lo scompenso cardiaco. 124
BNP e parametri ecocardiografici in pazienti ipertesi con insufficienza cardiaca. 123
Serum cholestrol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-Term Evaluation trial. 123
Effects of early ACE-inhibition in patients with no-STEMI acute myocardial infarction. 121
Early Treatment With Zofenopril And Ramipril In Combination With Acetyl Salicylic Acid In Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results Of A 5-Year Follow-Up Of Patients Of The Smile-4 Study 121
Cost effctiveness of zofenopril in patients with left ventricular systolic dysfunction afetr acute myocardial infarction: a post-hoc analysys of the smile-4 study. 120
Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study 120
Pharmacoeconomic approch to the treatment of hypertension: from clinical trials to clinical practice. 119
Compliance of antihypertensive treatment and monotherapy. Behaviour of the calcium-channel blocker lercanidipine 118
Choelsterol levels, plasma renin activity and incidence of stable hypertension in young subjects with high-normal blood pressure. 117
Aspetti ecocardiografici e sviluppo di disordini ipertensivi correlati alla gravidanza in donne gravide con alterazioni della flussimetria utero-placentare 117
Sondaggio sulla percezione clinica del rischio cardiovascolare nella pratica clinica. Risultati del sondaggio. 113
Ipertensione arteriosa e fattori di rischio in Italia: analisi dei rislutati dei principali studi osservazioni nazionali. 112
Effects of non steroidal anti-inflammatory drugs on clinical aspects and blood pressure in patients with heart failure. 110
Measuremnt and judgement of home blood pressure. 109
Sondaggio sulla percezione del rischio cariovascolare. Documento di consenso. 108
Ipertensione e fattori di rischio in Italia: analisi dei risultati dei principali studi osservazionali. 108
Dalla multidisciplinarità alla complessità clinica: come affrontare efficacemente la storia naturale della medicina 108
Erratum: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities [High Blood Press Cardiovasc Prev, (2014), 21, (29-36), DOI 10.1007/s40292-013-0034-z] 107
2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 107
Left ventricular systolic and diastolic function and geometric patterns in elderly hypertensives. 106
Compliance to antihypertensive treatment and monotherapy. Behavoiur of the calcium-channel blocker lercanidipine. 106
null 105
Consapevolezza, trattamento e controllo della pressione artersiosa e modificazioni temporali nell'impiego dei farmaci antiipertensivi. 104
Scienza, coscienza e portafoglio. 104
Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure. 104
Efficacy of Zofenopril Compared with Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies 102
Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study 101
La doxazosina compensa gli effetti indesiderati del beta-blocco. 100
Correlazione tra risposta al test cardiopolmonare a carico costante con la classe NYHA e con la frazione di eiezione ecocardiografica nei pazienti con insufficienza cardiaca. 97
Effect of an integrated approch to care in heart failure patients with compromised or preserved left ventricular function. 97
Denervazione delle arterie renali nel trattamento dell'ipertensione arteriosa resistente: definizione della patologia, selezione dei pazienti e descrizione della procedura. 96
Riduzione dell'incidenza di ospedalizazzione in una popolazione di pazienti affetti da insufficienza cardiaca seguiti attraverso un modello di gestione ambulatoriale integrata. 95
Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies. 95
Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies 95
COST EFFECTIVENESS OF ZOFENOPRIL IN THE TREATMENT OF PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AFTER ACUTE MYOCARDIAL INFARCTION: A POST-HOC ANALYSIS OF THE SMILE-4 STUDY 94
Il rischio cardiovascolare totale. 93
Pharmacoeconomic and cost-benefit aspects. 93
null 92
Tra scienza, coscienza e portafoglio: a chi l'ultima parola? 90
Prevalence of tinnitus in a population of hypertensive patients referring to a hypertensive clinic. 88
Left ventricualr structure and function and development of pregnancy-related hypertensive disorders in pregnant women with alterated utero-plancetal flow. 87
null 87
Zofenopril is a cost-effective treatment for patients with left ventricular systolic dysfunction following acute myocardial infarction: a pharmacoeconomic analysis of the SMILE-4 study 85
Zofenopril and ramipril plus ASA in post-myocardial infarction patients with left ventricular systolic dysfunction: a post-hoc analysis in preserved or impaired left ventricular fraction at entry 85
Confronto tra un AIIRA ed un Beta-bloccante sul controlo delal pressione arteriosa, emodinamica periferica e profilo lipidico in pazienti ipertesi dislipidemici trattati con una statina. 85
Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies 84
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Herat Study. 84
Effect of early ACE-inihibition in patients with acute myocardila infarction and metabolic syndrome. 83
Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension. 79
Monoterapia e compliance al trattamento antiipertensivo. Comportamento di un Ca-antagonista, lercanidipina 79
Influenza del diabete sui parametri clinici e strumentali di insufficienza cardiaca in una popolazione di pazienti ipertesi. 79
Assessment of b-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP in patients with heart failure of hypertensive or not hypertensive origin 78
Factors influencing the effect of statins on blood pressure in hypertensive patients. 78
Denervation of the renal arteries in the treatment of resistant hypertension: Definition of the disease, patient selection and description of the procedure. Reference document 2012 of the Italian Society of Hypertension (SIIA). [Denervazione delle arterie renali nel trattamento dell'ipertensione arteriosa resistente: Definizione della patologia, selezione dei pazienti e descrizione della procedura. Documento di indirizzo 2012 della Società Italiana dell'Ipertensione Arteriosa (SIIA)] 77
Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: A meta-analysis of individual data of four randomized, double-blind, prospective studies 77
Blood pressure control in Italy: results of recent surveys on hypertension. 77
null 76
Left ventricular structure and function and development of pregnancy-related hypertensive disorders in pregnant women with alterated utero-plancetal flow. 76
Left ventricular strutcture and function and development of pregnancy-related hypertensive disorders in pregnant women with alterated utero-placental flow. 75
Effects of AT1 receptor and beta1 receptor bloking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients. 75
null 74
null 74
null 73
Effetti della gestione ambulatoriale con approccio specialsitico dedicato del paziente iperteso con insufficienza cardiaca. 73
null 71
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosied hypertensive patients. 70
null 68
null 66
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: resuls of a randomized, double-blind, parallel-group, multiceter, european Study (SMILE-4). 66
null 65
Prevalence of tinnitus in a population of hypertensive patients reffering to a hypertensive clinic. 65
Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. 65
null 64
Totale 11.221
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021478 0 0 0 0 0 0 0 0 0 65 55 358
2021/20221.378 121 71 86 73 158 91 15 99 62 62 306 234
2022/20231.294 147 185 73 146 67 78 41 88 221 55 152 41
2023/2024346 16 60 28 25 24 65 22 36 13 23 16 18
2024/20251.605 64 286 126 94 475 70 93 11 27 15 38 306
2025/20263.470 204 401 427 267 402 275 338 285 638 233 0 0
Totale 12.260